FormWeb • riTUXimab-hyaluronidase

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

RiTUXimab-hyaluronidase

riTUXimab-hyaluronidase

Restricted Rituxan Hycela --> restricted to outpatient oncology.
Restricted Anti-Neoplastic Formulary

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Rituxan Hycela	SOLUTION, SUBCUTANEOUS	1,400 mg-23,400 units/11.7 mL, 1,600 mg-26,800 units/13.4 mL

Comments:

Restricted to oncology use in outpatient setting (clinic, outpatient medical). Not routinely stocked.

Patient should be observed/monitored for at least 15 minutes post-dose for signs of hypersensitivity or other adverse drug reactions.

Reviewed: 23 Jan 2018

Last updated: Mar. 5, 2025

Black Box Warning: Fatal Infusion Reaction; Mucocutaneous Reactions; Progressive Multifocal Leukoencephalopathy; Hep b Reactivation
Formulary, Not Routinely Stocked:

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.